ACTIVE

PHARMALEX

Export PDF

Financial year 2025 · closed on 30/06/2025

Net result

64,9 k €

-62.7% YoY

Gross margin

1,2 M €

-4.9% YoY

Equity

1,9 M €

+1.0% YoY

Workforce

15,0 ETP

+1.4% YoY

What does PHARMALEX do?

PHARMALEX is a Private limited company incorporated in 2000. Its main activity is: Accounting, bookkeeping and auditing activities; tax consultancy. Its registered office is in Liège. It employs on average 15,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0471.925.883

Incorporation

19/05/2000

Legal form

Private limited company

Registered office

Rue de Mulhouse 33 box B
4020 Liège · WallonieSee on map

Contributed capital

18 600,00 €

Latest accounts

30/06/2025

Average workforce

15,0 ETP

Activities (NACE)

69201Accounting, bookkeeping and auditing activities; tax consultancy· main 69201Accounting, bookkeeping and auditing activities; tax consultancy 74122Specialised design activities 74124Specialised design activities

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	1,2 M €	-4.9%	1,2 M €	-1.5%	1,2 M €	+107%	596 k €	-61.2%	1,5 M €	+9.2%	1,4 M €	+1.6%	1,4 M €	+1.9%	1,4 M €	+0.7%	1,3 M €	-0.5%	1,4 M €	-1.8%	1,4 M €	+1.4%	1,4 M €	+3.0%	1,3 M €	+7.5%	1,2 M €	+4.6%	1,2 M €	+4.1%	1,1 M €	+10.8%	1 M €	+9.3%	931,2 k €	+2.9%	905,1 k €	+24.6%	726,2 k €
EBITDA	90 k €	-64.6%	254,3 k €	-46.8%	478,1 k €	+101%	237,4 k €	-74.1%	915,3 k €	+22.9%	744,7 k €	-6.9%	800,2 k €	+11.7%	716,7 k €	+7.6%	666,1 k €	+2.0%	653,3 k €	+8.6%	601,4 k €	-0.2%	602,4 k €	+6.5%	565,9 k €	+4.7%	540,3 k €	+0.9%	535,5 k €	+8.2%	494,8 k €	+23.5%	400,7 k €	+8.5%	369,3 k €	+2.2%	361,6 k €	+88.5%	191,8 k €
Operating result	88,4 k €	-65.0%	252,8 k €	-47.1%	477,6 k €	+101%	237,2 k €	-74.1%	914,9 k €	+26.1%	725,4 k €	-6.3%	774,4 k €	+14.6%	675,9 k €	+7.0%	631,9 k €	+2.6%	615,9 k €	+5.6%	583,2 k €	+0.1%	582,8 k €	+7.0%	544,8 k €	+5.4%	516,7 k €	+0.8%	512,4 k €	+8.9%	470,6 k €	+29.1%	364,5 k €	+8.0%	337,4 k €	+1.4%	332,7 k €	+92.0%	173,3 k €
Net result	64,9 k €	-62.7%	174,2 k €	-52.8%	368,8 k €	+109%	176,6 k €	-75.0%	705,7 k €	+39.1%	507,4 k €	-2.8%	521,8 k €	+20.4%	433,2 k €	+18.8%	364,7 k €	-2.8%	375 k €	+5.8%	354,6 k €	-1.0%	358,3 k €	+5.2%	340,7 k €	+1.1%	336,9 k €	-1.0%	340,2 k €	+13.2%	300,4 k €	+24.4%	241,4 k €	+4.7%	230,5 k €	+3.0%	223,8 k €	+94.0%	115,3 k €
Balance sheet
Equity	1,9 M €	+1.0%	1,9 M €	-3.5%	2 M €	+3.5%	1,9 M €	-1.1%	1,9 M €	-2.1%	2 M €	+19.0%	1,6 M €	+44.3%	1,1 M €	-15.9%	1,4 M €	+36.7%	994,9 k €	+21.3%	819,9 k €	+7.1%	765,3 k €	+30.4%	587 k €	-3.2%	606,3 k €	+6.5%	569,5 k €	+7.6%	529,3 k €	+4.0%	508,9 k €	+13.7%	447,5 k €	+12.7%	397,1 k €	+1.0%	393,3 k €
Total assets	2,3 M €	-10.0%	2,5 M €	-1.4%	2,6 M €	+7.9%	2,4 M €	-17.2%	2,9 M €	-3.4%	3 M €	+10.5%	2,7 M €	+9.1%	2,5 M €	+5.2%	2,3 M €	+21.5%	1,9 M €	+7.1%	1,8 M €	+1.6%	1,8 M €	+6.4%	1,7 M €	+6.7%	1,6 M €	+14.3%	1,4 M €	+7.7%	1,3 M €	+29.4%	978 k €	+16.8%	837,3 k €	+14.3%	732,8 k €	+9.9%	666,7 k €
Cash	431,7 k €	+33.9%	322,4 k €	-20.8%	406,9 k €	-47.5%	774,6 k €	-66.0%	2,3 M €	+60.4%	1,4 M €	+48.0%	958,9 k €	-7.7%	1 M €	+1.8%	1 M €	+22.5%	833,4 k €	+13.6%	733,9 k €	-36.6%	1,2 M €	+56.3%	740 k €	+14.1%	648,6 k €	+6.8%	607,1 k €	-19.1%	750,5 k €	+32.8%	565 k €	+114%	263,4 k €	-21.4%	335,3 k €	+4.4%	321,1 k €
Debts	356 k €	-43.2%	626,8 k €	+5.6%	593,5 k €	+27.5%	465,6 k €	-50.5%	940,9 k €	-2.8%	968,2 k €	-2.2%	989,7 k €	-22.3%	1,3 M €	+38.0%	922,4 k €	+3.9%	888,2 k €	-6.0%	944,9 k €	-2.3%	967,5 k €	-7.1%	1 M €	+13.5%	917,5 k €	+15.8%	792,1 k €	+9.6%	722,9 k €	+59.7%	452,6 k €	+20.8%	374,7 k €	+12.9%	331,8 k €	+24.3%	266,9 k €
Other
Workforce	15,0 ETP	+1.4%	14,8 ETP	+8.8%	13,6 ETP		–		12,0 ETP	0.0%	12,0 ETP	-2.4%	12,3 ETP	+8.8%	11,3 ETP	-6.6%	12,1 ETP	-6.9%	13,0 ETP	-17.2%	15,7 ETP	0.0%	15,7 ETP	-2.5%	16,1 ETP	+4.5%	15,4 ETP	+29.4%	11,9 ETP	-13.1%	13,7 ETP	-1.4%	13,9 ETP	+11.2%	12,5 ETP	-0.8%	12,6 ETP	-3.8%	13,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 30/06/2025 · 3 active · 6 ended

Active mandates

AMARRIS HOLDING.BE

Director · since 01 novembre 2025 · 0776.947.036

Represented by Jordan Vandamme

Active

Guy Bernard

Director · since 20 juin 2022 · until 31 octobre 2025

Active

Philippe Meuleman

Director · since 20 juin 2022 · until 31 octobre 2025

Active

Ended mandates

Guy Bernard

Director · since 20 juin 2022

Ended

Philippe Meuleman

Director · since 20 juin 2022

Ended

Guy Bernard

Director

Ended

Guy Bernard

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
ALPHA● Active	1008.271.547
ALPHA FINANCE● Active	0444.692.243
Formation permanente● Active	0462.502.235
Laboratoires de Pharmacie Legia● Liquidation	0403.962.438
WALLONIE IMAGE PRODUCTION, asbl● Active	0431.001.682

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	6 months	12 months	12 months
Filing date	08/01/2026	19/12/2024	25/01/2024	23/12/2022	28/03/2022	31/05/2021
General meeting	19/12/2025	16/12/2024	16/12/2023	15/12/2022	28/02/2022	21/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	19/12/2025	08/01/2026	French	PDF
Abridged model	30/06/2024	16/12/2024	19/12/2024	French	PDF
Abridged modelCorrection	30/06/2023	29/12/2023	25/04/2024	French	PDF
Abridged model	30/06/2023	16/12/2023	25/01/2024	French	PDF
Abridged model	30/06/2022	15/12/2022	23/12/2022	French	PDF
Abridged model	31/12/2021	28/02/2022	28/03/2022	French	PDF
Abridged model	31/12/2020	21/05/2021	31/05/2021	French	PDF
Abridged model	31/12/2019	15/05/2020	16/07/2020	French	PDF
Abridged model	31/12/2018	28/02/2019	29/03/2019	French	PDF
Abridged model	31/12/2017	18/05/2018	27/06/2018	French	PDF
Abridged model	31/12/2016	22/05/2017	04/07/2017	French	PDF
Abridged model	31/12/2015	30/06/2016	05/08/2016	French	PDF
Abridged model	31/12/2014	09/04/2015	28/07/2015	French	PDF
Abridged model	31/12/2013	03/04/2014	29/08/2014	French	PDF
Abridged model	31/12/2012	30/04/2013	26/07/2013	French	PDF
Abridged model	31/12/2011	18/05/2012	24/07/2012	French	PDF
Abridged model	31/12/2010	20/05/2011	26/07/2011	French	PDF
Abridged model	31/12/2009	26/02/2010	29/07/2010	French	PDF
Abridged model	31/12/2008	08/05/2009	29/07/2009	French	PDF
Abridged model	31/12/2007	31/03/2008	22/07/2008	French	PDF
Abridged model	31/12/2006	30/04/2007	21/05/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 3 active · 6 ended

Active mandates

AMARRIS HOLDING.BE

Director · since 01 novembre 2025 · 0776.947.036

Represented by Jordan Vandamme

Active

Guy Bernard

Director · since 20 juin 2022 · until 31 octobre 2025

Active

Philippe Meuleman

Director · since 20 juin 2022 · until 31 octobre 2025

Active

Ended mandates

Guy Bernard

Director · since 20 juin 2022

Ended

Philippe Meuleman

Director · since 20 juin 2022

Ended

Guy Bernard

Director

Ended

Guy Bernard

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates28/02/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates28/06/2022
MODIFICATION FORME JURIDIQUE - OBJET - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE
PDF
Capital / shares22/01/2018
CAPITAL, ACTIONS
PDF
Capital / shares19/12/2013
CAPITAL, ACTIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202564,9 k €↓
2024
Annual accounts 2024174,2 k €↓
2023
Annual accounts 2023368,8 k €↑
2022
Annual accounts 2022176,6 k €↓
2021
Annual accounts 2021705,7 k €↑
2020
Annual accounts 2020507,4 k €↓
2019
Annual accounts 2019521,8 k €↑
2018
Annual accounts 2018433,2 k €↑
2017
Annual accounts 2017364,7 k €↓
2016
Annual accounts 2016375 k €↑
2015
Annual accounts 2015354,6 k €↓
2014
Annual accounts 2014358,3 k €↑
2013
Annual accounts 2013340,7 k €↑
2012
Annual accounts 2012336,9 k €↓
2011
Annual accounts 2011340,2 k €↑
2010
Annual accounts 2010300,4 k €↑
2009
Annual accounts 2009241,4 k €↑
2008
Annual accounts 2008230,5 k €↑
2007
Annual accounts 2007223,8 k €↑
2006
Annual accounts 2006115,3 k €
19/05/2000
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMALEX

Overview

What does PHARMALEX do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline